Related Experiment Video
Updated: Aug 17, 2026

Measuring Bacterial Load and Immune Responses in Mice Infected with Listeria monocytogenes
Published on: August 9, 2011
Listeria cerebritis: relapse of infection in renal transplant patients
Abstract:
In 3 cases of Listeria cerebritis, two of the patients had relapse with cerebritis after antimicrobial therapy for acute Listeria septicemia or meningitis. Each had received ten to 14 days of intravenous penicillin. Relapse occurred with fever and sudden focal cerebral dysfunction. Brain scans showed focal uptake; arteriograms and computerized tomography were normal. Cerebrospinal fluids were nondiagnostic; blood cultures yielded Listeria in two patients. Penicillin treatment for six weeks produced rapid clinical responses that were complete in one and minimal residual in two. Progress brain scans were normal. A relapse rate of 35% is reported in transplant patients with Listeria meningitis and/or bacteremia who are treated for less than three weeks; to our knowledge, cerebritis in such patients has not been reported previously. High-dose penicillin or ampicillin therapy for four to six weeks is recommended for Listeria infections in this select group.
Insights
Listeria cerebritis relapsed in two patients despite initial antimicrobial treatment. Extended penicillin therapy for six weeks led to significant clinical improvement, suggesting longer treatment durations are crucial for these infections.
Area of Science:
- Neurology
- Infectious Diseases
- Microbiology
Background:
- Listeria infections, including septicemia and meningitis, can occur in immunocompromised individuals.
- Cerebritis, an inflammation of the brain, is a serious complication of Listeria infections.
Observation:
- Two of three patients with Listeria cerebritis experienced relapse after 10-14 days of intravenous penicillin therapy.
- Relapse presented with fever and acute focal cerebral dysfunction, while initial diagnostic tests were inconclusive.
Findings:
- Extended six-week penicillin treatment resulted in rapid clinical responses for patients with relapsed Listeria cerebritis.
- Brain imaging normalized after the prolonged treatment course, indicating resolution of the cerebritis.
Implications:
- A high relapse rate (35%) is noted in transplant patients with Listeria meningitis/bacteremia treated for less than three weeks.
- This study highlights the potential for cerebritis relapse and recommends high-dose penicillin or ampicillin therapy for four to six weeks for Listeria infections in select patient groups.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury III: Clinical Manifestations
Cryptococcal Meningitis

